Fig 2. Distribution of site-level changes in 6-month cumulative incidence of antiretroviral treatment initiation (CI-ART) after expansions to CD4 ≤ 350 and CD4 ≤ 500, by patient ART eligibility status at enrollment.

^a Defined as those enrolling at CD4 ≤ 200 (in the expansion to CD4 ≤ 350 analysis) and those enrolling at CD4 between 201 and 350 (in the expansion to CD4 ≤ 500 analysis). ^b Defined as those enrolling at CD4 ≤ 350 (in the expansion to CD4 ≤ 350 analysis) and those enrolling at CD4 between 351 and 500 (in the expansion to CD4 ≤ 500 analysis).